BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Lipitor, rs2300478, IGF1, Apoptosis, Obesity, Prostate, Autoimmunity)
Bookmark Forward

QuickView for PU.1 (gene)


Body Atlas

Most Correlated Tissues

  1. Whole blood
  2. Neutrophil of bone marrow
  3. Leukocyte (polymorphonuclear) of peripheral blood
  4. Microglial cell
  5. Mononuclear cell of peripheral blood
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Fungal keratitis
  2. Sepsis due to coagulase negative Staphylococcus
  3. Fusarium infection
  4. Systemic infection
  5. Salmonella infection
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. poly ICLC
  2. Ions
  3. Chlorphenesin
  4. piperaquine
  5. dihydroquinghaosu
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. PINK1
  2. LYRM1
  3. SPI1
  4. CASP1
  5. EN1
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. DNA selection by the master transcription factor PU.1.
  2. PU.1 negatively regulates tumorigenesis in non-small-cell lung cancer.
  3. Combined Approach to Leukemic Differentiation Using Transcription Factor PU.1-Enhancing Agents.
  4. Blood stem cell PU.1 upregulation is a consequence of differentiation without fast autoregulation.
  5. Intracellular Salmonella Paratyphi A is motile and differs in the expression of flagella-chemotaxis,…
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. FoxO3a and PU.1 in Acute Lymphoblastic Leukemia
  2. PET Imaging of Subjects Using 124I-PU-AD
  3. A Single and Multiple Ascending Dose Study to Evaluate the Safety and Pharmacokinetics of PU-AD in H…
  4. Evaluation of Ruxolitinib in Combination With PU-H71 for Treatment of Myelofibrosis
  5. To Evaluate Safety, Tolerability and Pharmacological Effects of PU AD in Subjects With Mild AD Demen…
Explore Clinical Trials Results
  • Copyright © 2023 Illumina Inc. All rights reserved.